Pecori Giraldi Francesca, Ambrogio Alberto G, De Martin Martina, Fatti Letizia M, Scacchi Massimo, Cavagnini Francesco
University of Milan, Ospedale San Luca, via Spagnoletto 3, I-20149 Milan, Italy.
J Clin Endocrinol Metab. 2007 Nov;92(11):4123-9. doi: 10.1210/jc.2007-0596. Epub 2007 Aug 14.
The diagnosis of Cushing's syndrome requires highly sensitive screening tests. Therefore, diagnostic cutoffs have been lowered to maximize sensitivity and identify all patients. However, few studies have investigated the impact of these refinements on the specificity of first-line tests.
The aim of the study was the assessment of the specificity of three widely used screening tests in a large series of Cushing's syndrome suspects referred to our endocrine service.
We retrospectively reviewed the results of urinary free cortisol (UFC), 1-mg dexamethasone suppression test [overnight suppression test (OST)], and serum cortisol at midnight in 3,461, 357, and 864 patients, respectively, with clinical features suggestive of Cushing's syndrome but in whom this diagnosis was subsequently excluded.
UFC and OST at the 5-microg/dl cutoff exhibited the highest specificities [91% (95% confidence intervals [CI] 90.2-92.1%) and 97% (95% CI 96.3-98.5%), respectively]. Conversely, midnight serum cortisol yielded 87% (95% CI 84.3-91.1%) specificity only with the 7.5-microg/dl cutoff, whereas the 1.8-microg/dl threshold resulted in an unacceptably high proportion of false positives at only 20% specificity (95% CI 16.0-24.4%). Gender and age may lead to misleading results in all three screening tests.
Specificity of tests for Cushing's syndrome varies considerably, with OST and UFC presenting the best performances, and circadian rhythm appearing heavily impaired by lowering of diagnostic cutoffs. Indeed, the vast majority of individuals in our series presented midnight serum cortisol values greater than 1.8 microg/dl; thus, caution has to be exercised when this criterion is used to exclude Cushing's syndrome.
库欣综合征的诊断需要高度敏感的筛查试验。因此,诊断阈值已经降低以最大化敏感性并识别所有患者。然而,很少有研究调查这些改进对一线检测特异性的影响。
本研究的目的是评估在转诊至我们内分泌科的大量疑似库欣综合征患者中,三种广泛使用的筛查试验的特异性。
我们回顾性分析了分别对3461例、357例和864例患者进行的尿游离皮质醇(UFC)、1毫克地塞米松抑制试验[过夜抑制试验(OST)]和午夜血清皮质醇检测结果,这些患者具有提示库欣综合征的临床特征,但随后排除了该诊断。
UFC和5微克/分升阈值的OST表现出最高的特异性[分别为91%(95%置信区间[CI]90.2 - 92.1%)和97%(95%CI 96.3 - 98.5%)]。相反,午夜血清皮质醇仅在7.5微克/分升阈值时特异性为87%(95%CI 84.3 - 91.1%),而1.8微克/分升阈值时假阳性比例高得令人无法接受,特异性仅为20%(95%CI 16.0 - 24.4%)。性别和年龄可能在所有三种筛查试验中导致误导性结果。
库欣综合征检测的特异性差异很大,OST和UFC表现最佳,并且诊断阈值的降低似乎严重损害了昼夜节律。实际上,我们系列中的绝大多数个体午夜血清皮质醇值大于1.8微克/分升;因此,当使用该标准排除库欣综合征时必须谨慎。